• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-Term Control of Oligometastatic Prostate Cancer After Stereotactic Body Radiotherapy in the Absence of Androgen Deprivation Therapy: A Case Report.

作者信息

Markowski Mark C, Imus Philip, Wright Jean L, Schottenstein Douglas, Paller Channing J

机构信息

Department of Oncology, Johns Hopkins University, Baltimore, MD.

Department of Oncology, Johns Hopkins University, Baltimore, MD.

出版信息

Clin Genitourin Cancer. 2017 Oct;15(5):e839-e842. doi: 10.1016/j.clgc.2017.02.001. Epub 2017 Feb 27.

DOI:10.1016/j.clgc.2017.02.001
PMID:28325637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5801746/
Abstract
摘要

相似文献

1
Long-Term Control of Oligometastatic Prostate Cancer After Stereotactic Body Radiotherapy in the Absence of Androgen Deprivation Therapy: A Case Report.立体定向体部放疗后在无雄激素剥夺治疗情况下寡转移前列腺癌的长期控制：一例报告
Clin Genitourin Cancer. 2017 Oct;15(5):e839-e842. doi: 10.1016/j.clgc.2017.02.001. Epub 2017 Feb 27.
2
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.立体定向分次放疗治疗多达 5 个前列腺癌寡转移灶：一项前瞻性临床试验的中期结果。
Int J Cancer. 2020 Jan 1;146(1):161-168. doi: 10.1002/ijc.32509. Epub 2019 Jun 28.
3
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.氟[18F]甲基胆碱 PET/CT 探测到的激素敏感性前列腺癌寡转移同期发生患者中应用立体定向体部放疗的获益。
Clin Genitourin Cancer. 2017 Oct;15(5):e773-e782. doi: 10.1016/j.clgc.2017.03.009. Epub 2017 Mar 29.
4
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes.挽救性立体定向体部放射治疗孤立性淋巴结复发前列腺癌：单机构94例连续患者及124个淋巴结系列研究
Clin Genitourin Cancer. 2017 Aug;15(4):e623-e632. doi: 10.1016/j.clgc.2017.01.004. Epub 2017 Jan 11.
5
A Review of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Prostate Cancer.立体定向体部放射治疗寡转移前列腺癌的研究进展。
Anticancer Res. 2020 May;40(5):2419-2428. doi: 10.21873/anticanres.14211.
6
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.[18F]胆碱正电子发射断层显像/计算机断层扫描与立体定向体部放疗在寡转移前列腺癌患者治疗决策中的应用：初步结果
Radiat Oncol. 2016 Jan 22;11:9. doi: 10.1186/s13014-016-0586-x.
7
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO).寡转移前列腺癌消融性放疗共识声明：意大利放射治疗和肿瘤临床学会（AIRO）立场文件。
Crit Rev Oncol Hematol. 2019 Jun;138:24-28. doi: 10.1016/j.critrevonc.2019.03.014. Epub 2019 Apr 1.
8
Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.寡转移前列腺癌的局部消融立体定向体部放射治疗
Curr Opin Support Palliat Care. 2018 Sep;12(3):351-358. doi: 10.1097/SPC.0000000000000371.
9
Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer.局部前列腺癌机器人立体定向体部放疗后的前列腺特异性抗原动力学
Acta Oncol. 2015 Jun;54(6):832-8. doi: 10.3109/0284186X.2014.983656. Epub 2014 Dec 3.
10
CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes: Single-Center Study Outcome Evaluation.射波刀立体定向消融放疗作为寡转移淋巴结前列腺癌患者的一种治疗选择：单中心研究结果评估
Technol Cancer Res Treat. 2016 Oct;15(5):661-73. doi: 10.1177/1533034615595945. Epub 2015 Jul 24.

引用本文的文献

1
Local Therapies in Oligometastatic and Oligoprogressive Prostate Cancer.寡转移和寡进展性前列腺癌的局部治疗。
Semin Radiat Oncol. 2021 Jul;31(3):242-249. doi: 10.1016/j.semradonc.2021.03.007.
2
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).镭-223 二氯化物联合立体定向消融放疗与立体定向消融放疗治疗寡转移去势抵抗性前列腺癌的随机 II 期研究（RAVENS）。
BMC Cancer. 2020 Jun 1;20(1):492. doi: 10.1186/s12885-020-07000-2.
3
Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.寡转移和寡进展疾病与前列腺癌的局部治疗。
Cancer J. 2020 Mar/Apr;26(2):137-143. doi: 10.1097/PPO.0000000000000432.
4
Oligometastatic prostate cancer: Reality or figment of imagination?寡转移前列腺癌：现实还是臆想？
Cancer. 2019 Feb 1;125(3):340-352. doi: 10.1002/cncr.31860. Epub 2018 Dec 6.

本文引用的文献

1
Stereotactic body radiation therapy (SBRT) delays the emergence of castration resistance in patients with oligometastatic prostate cancer.
Clin Transl Oncol. 2016 Jul;18(7):743-7. doi: 10.1007/s12094-015-1414-8. Epub 2015 Oct 19.
2
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis.寡转移去势抵抗性前列腺癌立体定向体部放疗后无进展生存的多中心分析。
Eur Urol. 2016 Jan;69(1):9-12. doi: 10.1016/j.eururo.2015.07.004. Epub 2015 Jul 16.
3
SBRT: An Opportunity to Improve Quality of Life for Oligometastatic Prostate Cancer.立体定向体部放疗：改善寡转移前列腺癌患者生活质量的契机
Front Oncol. 2015 May 5;5:101. doi: 10.3389/fonc.2015.00101. eCollection 2015.
4
Risk and timing of cardiovascular disease after androgen-deprivation therapy in men with prostate cancer.男性前列腺癌患者接受雄激素剥夺治疗后的心血管疾病风险和时间。
J Clin Oncol. 2015 Apr 10;33(11):1243-51. doi: 10.1200/JCO.2014.59.1792. Epub 2015 Mar 2.
5
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.立体定向体部放疗重复治疗寡转移前列腺癌复发
Radiat Oncol. 2014 Jun 12;9:135. doi: 10.1186/1748-717X-9-135.
6
Diagnostic challenges of clonal heterogeneity in prostate cancer.前列腺癌中克隆异质性的诊断挑战
J Clin Oncol. 2015 Mar 1;33(7):e38-40. doi: 10.1200/JCO.2013.50.3540. Epub 2014 Mar 17.
7
Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer.立体定向体部放射治疗在治疗寡转移激素初治前列腺癌患者中的原理。
Front Oncol. 2013 Dec 3;3:293. doi: 10.3389/fonc.2013.00293.
8
Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective.去势抵抗性前列腺癌的适应和克隆选择模型：当前观点。
Int J Urol. 2013 Apr;20(4):362-71. doi: 10.1111/iju.12005. Epub 2012 Nov 19.
9
Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.寡转移病灶行立体定向体部放疗治疗：前瞻性研究的长期随访。
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):878-86. doi: 10.1016/j.ijrobp.2011.08.036. Epub 2011 Dec 13.
10
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.根治性前列腺切除术后生化复发后前列腺癌特异性死亡风险。
JAMA. 2005 Jul 27;294(4):433-9. doi: 10.1001/jama.294.4.433.